These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 39067792)

  • 21. Antigen epitope-TLR7/8a conjugate as self-assembled carrier-free nanovaccine for personalized immunotherapy.
    Song H; Su Q; Shi W; Huang P; Zhang C; Zhang C; Liu Q; Wang W
    Acta Biomater; 2022 Mar; 141():398-407. PubMed ID: 35007785
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Vaccination with filamentous bacteriophages targeting DEC-205 induces DC maturation and potent anti-tumor T-cell responses in the absence of adjuvants.
    Sartorius R; Bettua C; D'Apice L; Caivano A; Trovato M; Russo D; Zanoni I; Granucci F; Mascolo D; Barba P; Del Pozzo G; De Berardinis P
    Eur J Immunol; 2011 Sep; 41(9):2573-84. PubMed ID: 21688262
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Engineering ApoE3-incorporated biomimetic nanoparticle for efficient vaccine delivery to dendritic cells via macropinocytosis to enhance cancer immunotherapy.
    Zhou S; Huang Y; Chen Y; Liu S; Xu M; Jiang T; Song Q; Jiang G; Gu X; Gao X; Chen J
    Biomaterials; 2020 Mar; 235():119795. PubMed ID: 32014739
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Uplifting Antitumor Immunotherapy with Lymph-Node-Targeted and Ratio-Controlled Codelivery of Tumor Cell Lysate and Adjuvant.
    Cui G; Sun Y; Qu L; Shen C; Sun Y; Meng F; Zheng Y; Zhong Z
    Adv Healthc Mater; 2024 Jul; 13(17):e2303690. PubMed ID: 38458152
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Chemical Conjugation of a Purified DEC-205-Directed Antibody with Full-Length Protein for Targeting Mouse Dendritic Cells In Vitro and In Vivo.
    Volckmar J; Knop L; Hirsch T; Frentzel S; Erck C; van Ham M; Stegemann-Koniszewski S; Bruder D
    J Vis Exp; 2021 Feb; (168):. PubMed ID: 33616089
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Glucosylated Nanovaccines for Dendritic Cell-Targeted Antigen Delivery and Amplified Cancer Immunotherapy.
    Liu J; Cui Y; Cabral H; Tong A; Yue Q; Zhao L; Sun X; Mi P
    ACS Nano; 2024 Sep; 18(37):25826-25840. PubMed ID: 39196858
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Targeting of DEC-205 on human dendritic cells results in efficient MHC class II-restricted antigen presentation.
    Birkholz K; Schwenkert M; Kellner C; Gross S; Fey G; Schuler-Thurner B; Schuler G; Schaft N; Dörrie J
    Blood; 2010 Sep; 116(13):2277-85. PubMed ID: 20566893
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The enhanced antitumor-specific immune response with mannose- and CpG-ODN-coated liposomes delivering TRP2 peptide.
    Lai C; Duan S; Ye F; Hou X; Li X; Zhao J; Yu X; Hu Z; Tang Z; Mo F; Yang X; Lu X
    Theranostics; 2018; 8(6):1723-1739. PubMed ID: 29556352
    [TBL] [Abstract][Full Text] [Related]  

  • 29. ISCOMATRIX adjuvant combines immune activation with antigen delivery to dendritic cells in vivo leading to effective cross-priming of CD8+ T cells.
    Duewell P; Kisser U; Heckelsmiller K; Hoves S; Stoitzner P; Koernig S; Morelli AB; Clausen BE; Dauer M; Eigler A; Anz D; Bourquin C; Maraskovsky E; Endres S; Schnurr M
    J Immunol; 2011 Jul; 187(1):55-63. PubMed ID: 21613613
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Minimalist Nanovaccine with Optimized Amphiphilic Copolymers for Cancer Immunotherapy.
    Niu L; Miao Y; Cao Z; Wei T; Zhu J; Li M; Bai B; Chen L; Liu N; Pan F; Zhu J; Wang C; Yang Y; Chen Q
    ACS Nano; 2024 Jan; 18(4):3349-3361. PubMed ID: 38230639
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Tumor growth inhibition by mSTEAP peptide nanovaccine inducing augmented CD8
    Chen Q; Bao Y; Burner D; Kaushal S; Zhang Y; Mendoza T; Bouvet M; Ozkan C; Minev B; Ma W
    Drug Deliv Transl Res; 2019 Dec; 9(6):1095-1105. PubMed ID: 31228097
    [TBL] [Abstract][Full Text] [Related]  

  • 32. PLGA-
    Cao Q; Zhou R; Guo S; Meng K; Yang X; Liu M; Ma B; Su C; Duan X
    Int J Nanomedicine; 2024; 19():9437-9458. PubMed ID: 39290859
    [TBL] [Abstract][Full Text] [Related]  

  • 33. PLGA nanoparticle-mediated delivery of tumor antigenic peptides elicits effective immune responses.
    Ma W; Chen M; Kaushal S; McElroy M; Zhang Y; Ozkan C; Bouvet M; Kruse C; Grotjahn D; Ichim T; Minev B
    Int J Nanomedicine; 2012; 7():1475-87. PubMed ID: 22619507
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Rational design of nanoparticles towards targeting antigen-presenting cells and improved T cell priming.
    Zupančič E; Curato C; Paisana M; Rodrigues C; Porat Z; Viana AS; Afonso CAM; Pinto J; Gaspar R; Moreira JN; Satchi-Fainaro R; Jung S; Florindo HF
    J Control Release; 2017 Jul; 258():182-195. PubMed ID: 28511928
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Activation of antigen-specific T cell-responses by mannan-decorated PLGA nanoparticles.
    Hamdy S; Haddadi A; Shayeganpour A; Samuel J; Lavasanifar A
    Pharm Res; 2011 Sep; 28(9):2288-301. PubMed ID: 21560020
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Improved vaccine-induced immune responses via a ROS-triggered nanoparticle-based antigen delivery system.
    Liang X; Duan J; Li X; Zhu X; Chen Y; Wang X; Sun H; Kong D; Li C; Yang J
    Nanoscale; 2018 May; 10(20):9489-9503. PubMed ID: 29675543
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Enhanced antitumor immunity by targeting dendritic cells with tumor cell lysate-loaded chitosan nanoparticles vaccine.
    Shi GN; Zhang CN; Xu R; Niu JF; Song HJ; Zhang XY; Wang WW; Wang YM; Li C; Wei XQ; Kong DL
    Biomaterials; 2017 Jan; 113():191-202. PubMed ID: 27816821
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Self-adjuvanting nanoemulsion targeting dendritic cell receptor Clec9A enables antigen-specific immunotherapy.
    Zeng B; Middelberg AP; Gemiarto A; MacDonald K; Baxter AG; Talekar M; Moi D; Tullett KM; Caminschi I; Lahoud MH; Mazzieri R; Dolcetti R; Thomas R
    J Clin Invest; 2018 May; 128(5):1971-1984. PubMed ID: 29485973
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Targeting dendritic cells with antigen-containing liposomes: a highly effective procedure for induction of antitumor immunity and for tumor immunotherapy.
    van Broekhoven CL; Parish CR; Demangel C; Britton WJ; Altin JG
    Cancer Res; 2004 Jun; 64(12):4357-65. PubMed ID: 15205352
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Assessment of the enhancement of PLGA nanoparticle uptake by dendritic cells through the addition of natural receptor ligands and monoclonal antibody.
    Walters AA; Somavarapu S; Riitho V; Stewart GR; Charleston B; Steinbach F; Graham SP
    Vaccine; 2015 Nov; 33(48):6588-95. PubMed ID: 26529067
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.